SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parenteral Drugs (India) informs about board meeting

14 Aug 2017 Evaluate

Parenteral Drugs (India) has informed that the board fixed the record date for the purpose of closure of the register of members and share transfer books pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which will commence from 23rd September, 2017 to 29th September, 2017. Further, the 33rd Annual General Meeting of the company will be held on Friday, the 29th day of September, 2017, at 9.30 a.m. at the Classique Club, Behind Infinity Mall, Link Road, Oshiwara, Andheri (West), Mumbai-400 053.

The above information is a part of company’s filings submitted to BSE.

Parenteral Drugs Share Price

3.39 0.00 (0.00%)
21-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.20
Dr. Reddys Lab 1295.65
Cipla 1314.50
Zydus Lifesciences 943.65
Lupin 2267.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×